CorMedix IncNASDAQ:CRMD
- LAST PRICE9.9500
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots10.0100/ 1
- Ask / Lots10.4000/ 1
- Open / Previous Close--- / 9.9500
- Day Range---
- 52 Week Range
- Volume318
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CRMD |
|---|---|---|
| 09:32 ET | 15635 | 10.0445 |
| 09:33 ET | 3092 | 10.02 |
| 09:35 ET | 2720 | 10.085 |
| 09:37 ET | 6276 | 10.175 |
| 09:39 ET | 9735 | 10.15 |
| 09:42 ET | 2051 | 10.175 |
| 09:44 ET | 4245 | 10.165 |
| 09:46 ET | 6615 | 10.185 |
| 09:48 ET | 11670 | 10.2 |
| 09:50 ET | 14087 | 10.08 |
| 09:51 ET | 23931 | 10.1 |
| 09:53 ET | 1535 | 10.0699 |
| 09:55 ET | 3026 | 10 |
| 09:57 ET | 14787 | 10.055 |
| 10:00 ET | 2247 | 10.065 |
| 10:02 ET | 2420 | 10.08 |
| 10:04 ET | 2660 | 10.0711 |
| 10:06 ET | 202 | 10.09 |
| 10:08 ET | 100 | 10.14 |
| 10:09 ET | 1913 | 10.18 |
| 10:13 ET | 162 | 10.18 |
| 10:15 ET | 2895 | 10.145 |
| 10:18 ET | 1068 | 10.15 |
| 10:20 ET | 6033 | 10.1 |
| 10:22 ET | 2400 | 10.13 |
| 10:24 ET | 900 | 10.19 |
| 10:26 ET | 663 | 10.21 |
| 10:27 ET | 2101 | 10.24 |
| 10:29 ET | 1095 | 10.2393 |
| 10:31 ET | 300 | 10.2228 |
| 10:33 ET | 5911 | 10.19 |
| 10:36 ET | 100 | 10.21 |
| 10:38 ET | 100 | 10.22 |
| 10:40 ET | 200 | 10.23 |
| 10:42 ET | 400 | 10.22 |
| 10:44 ET | 2500 | 10.2 |
| 10:45 ET | 1600 | 10.19 |
| 10:47 ET | 1978 | 10.16 |
| 10:49 ET | 1694 | 10.2353 |
| 10:51 ET | 7072 | 10.2 |
| 10:54 ET | 107 | 10.2 |
| 10:56 ET | 1145 | 10.2041 |
| 10:58 ET | 3694 | 10.22 |
| 11:02 ET | 300 | 10.195 |
| 11:03 ET | 600 | 10.195 |
| 11:05 ET | 300 | 10.2 |
| 11:07 ET | 486 | 10.205 |
| 11:12 ET | 3331 | 10.18 |
| 11:14 ET | 390 | 10.19 |
| 11:16 ET | 2551 | 10.17 |
| 11:18 ET | 4264 | 10.195 |
| 11:20 ET | 616 | 10.195 |
| 11:21 ET | 100 | 10.2 |
| 11:23 ET | 1308 | 10.2 |
| 11:25 ET | 500 | 10.21 |
| 11:27 ET | 2979 | 10.2501 |
| 11:30 ET | 2000 | 10.275 |
| 11:32 ET | 200 | 10.255 |
| 11:34 ET | 1200 | 10.27 |
| 11:36 ET | 3478 | 10.24 |
| 11:39 ET | 2617 | 10.2 |
| 11:41 ET | 2600 | 10.2 |
| 11:43 ET | 450 | 10.205 |
| 11:48 ET | 1286 | 10.21 |
| 11:50 ET | 100 | 10.205 |
| 11:52 ET | 221 | 10.205 |
| 11:54 ET | 5060 | 10.28 |
| 11:56 ET | 700 | 10.2715 |
| 11:57 ET | 3344 | 10.3 |
| 11:59 ET | 1000 | 10.2804 |
| 12:01 ET | 2700 | 10.27 |
| 12:03 ET | 100 | 10.27 |
| 12:06 ET | 2050 | 10.3 |
| 12:08 ET | 190 | 10.3 |
| 12:10 ET | 600 | 10.3 |
| 12:12 ET | 5218 | 10.23 |
| 12:14 ET | 1900 | 10.2 |
| 12:15 ET | 400 | 10.19 |
| 12:19 ET | 400 | 10.18 |
| 12:21 ET | 684 | 10.16 |
| 12:24 ET | 1300 | 10.12 |
| 12:26 ET | 1100 | 10.08 |
| 12:28 ET | 8845 | 10.056 |
| 12:32 ET | 2838 | 10.06 |
| 12:33 ET | 812 | 10.06 |
| 12:37 ET | 100 | 10.055 |
| 12:39 ET | 812 | 10.07 |
| 12:42 ET | 200 | 10.07 |
| 12:46 ET | 1474 | 10.07 |
| 12:48 ET | 542 | 10.06 |
| 12:50 ET | 300 | 10.035 |
| 12:51 ET | 674 | 10.076 |
| 12:53 ET | 600 | 10.07 |
| 12:55 ET | 958 | 10.0737 |
| 12:57 ET | 100 | 10.07 |
| 01:00 ET | 1155 | 10.1 |
| 01:02 ET | 2183 | 10.08 |
| 01:06 ET | 1802 | 10.08 |
| 01:08 ET | 335 | 10.07 |
| 01:09 ET | 600 | 10.0771 |
| 01:11 ET | 2706 | 10.07 |
| 01:13 ET | 600 | 10.072 |
| 01:18 ET | 200 | 10.09 |
| 01:20 ET | 341 | 10.09 |
| 01:22 ET | 800 | 10.11 |
| 01:24 ET | 200 | 10.09 |
| 01:27 ET | 522 | 10.11 |
| 01:29 ET | 545 | 10.09 |
| 01:31 ET | 104 | 10.09 |
| 01:33 ET | 570 | 10.11 |
| 01:36 ET | 100 | 10.115 |
| 01:38 ET | 2300 | 10.105 |
| 01:40 ET | 400 | 10.1 |
| 01:44 ET | 1233 | 10.09 |
| 01:45 ET | 16936 | 10.07 |
| 01:47 ET | 1077 | 10.1 |
| 01:51 ET | 300 | 10.07 |
| 01:56 ET | 19321 | 9.995 |
| 02:00 ET | 13465 | 9.94 |
| 02:02 ET | 1458 | 9.94 |
| 02:03 ET | 700 | 9.96 |
| 02:05 ET | 4425 | 10.025 |
| 02:07 ET | 300 | 10.01 |
| 02:09 ET | 5337 | 10.03 |
| 02:12 ET | 925 | 10.03 |
| 02:14 ET | 2000 | 10.0207 |
| 02:16 ET | 3832 | 10.02 |
| 02:18 ET | 319 | 10.01 |
| 02:21 ET | 631 | 10.01 |
| 02:23 ET | 12202 | 9.94 |
| 02:25 ET | 2942 | 9.93 |
| 02:27 ET | 1525 | 9.94 |
| 02:30 ET | 1007 | 9.95 |
| 02:32 ET | 6245 | 9.96 |
| 02:34 ET | 1159 | 9.94 |
| 02:36 ET | 500 | 9.93 |
| 02:38 ET | 4738 | 9.9295 |
| 02:39 ET | 3740 | 9.93 |
| 02:41 ET | 400 | 9.92 |
| 02:43 ET | 900 | 9.9493 |
| 02:45 ET | 6540 | 9.9249 |
| 02:48 ET | 2363 | 9.97 |
| 02:50 ET | 575 | 9.96 |
| 02:52 ET | 550 | 9.95 |
| 02:54 ET | 3900 | 9.97 |
| 02:56 ET | 1200 | 9.96 |
| 02:57 ET | 2926 | 9.95 |
| 03:01 ET | 1178 | 9.95 |
| 03:03 ET | 823 | 9.96 |
| 03:06 ET | 8001 | 9.89 |
| 03:08 ET | 1233 | 9.92 |
| 03:10 ET | 1450 | 9.91 |
| 03:12 ET | 1450 | 9.94 |
| 03:14 ET | 967 | 9.92 |
| 03:15 ET | 990 | 9.95 |
| 03:17 ET | 900 | 9.965 |
| 03:19 ET | 2544 | 9.94 |
| 03:21 ET | 500 | 9.92 |
| 03:24 ET | 500 | 9.94 |
| 03:26 ET | 920 | 9.94 |
| 03:28 ET | 3164 | 9.92 |
| 03:30 ET | 12671 | 9.9104 |
| 03:32 ET | 7136 | 9.91 |
| 03:33 ET | 3400 | 9.9221 |
| 03:35 ET | 850 | 9.92 |
| 03:37 ET | 900 | 9.93 |
| 03:39 ET | 4152 | 9.9 |
| 03:42 ET | 1300 | 9.94 |
| 03:44 ET | 10828 | 9.9 |
| 03:46 ET | 7037 | 9.88 |
| 03:48 ET | 2675 | 9.86 |
| 03:50 ET | 2578 | 9.87 |
| 03:51 ET | 8840 | 9.99 |
| 03:53 ET | 5171 | 9.98 |
| 03:55 ET | 7372 | 9.95 |
| 03:57 ET | 20497 | 9.97 |
| 04:00 ET | 128949 | 9.95 |
Nov 4, 2024
CorMedix Inc. to Participate in the Truist Securities BioPharma Symposium, from 8:30AM ET on Monday Nov 04, 2024 by Dow Jones
8:30AM ET on Monday Nov 04, 2024 by Dow Jones
Oct 31, 2024
DJ CorMedix Is Maintained at Buy by Needham, from 6:21AM ET on Thursday Oct 31, 2024 by Dow Jones
6:21AM ET on Thursday Oct 31, 2024 by Dow Jones
Oct 30, 2024
DJ CorMedix Down Over 15%, On Pace for Largest Percent Decrease Since June 2023 -- Data Talk, from 11:56AM ET on Wednesday Oct 30, 2024 by Dow Jones
11:56AM ET on Wednesday Oct 30, 2024 by Dow Jones*DJ CorMedix 3Q Loss/Shr 5c >CRMD, from 7:30AM ET on Wednesday Oct 30, 2024 by Dow Jones
7:30AM ET on Wednesday Oct 30, 2024 by Dow JonesCorMedix Inc. Reports Third Quarter and Nine Month 2024 Financial Results and Provides Business Update, from 7:30AM ET on Wednesday Oct 30, 2024 by Dow Jones
7:30AM ET on Wednesday Oct 30, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
CorMedix Inc | 604.3M | -12.4x | --- |
Zevra Therapeutics Inc | 511.6M | -4.8x | --- |
Elite Pharmaceuticals Inc | 658.9M | -103.6x | --- |
Eton Pharmaceuticals Inc | 290.1M | -56.4x | --- |
Cipla Ltd | 14.4B | 0.0x | --- |
Incannex Healthcare Inc | 34.9M | -1.4x | --- |
Company Information
CorMedix Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases. The Company is focused on commercializing its lead product DefenCath, which is an antimicrobial catheter lock solution approved to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure receiving chronic hemodialysis through a central venous catheter. DefenCath is a formulation of taurolidine 13.5 mg/mL, and heparin 1000 USP Units/mL indicated to reduce the incidence of catheter-related bloodstream infections (CRBSI) in adult patients with kidney failure receiving chronic hemodialysis through a central venous catheter (CVC). In addition to DefenCath, the Company has sponsored a pre-clinical research collaboration for the use of taurolidine as a possible treatment for rare pediatric tumors.
Contact Information
- Headquarters
- 300 Connell Drive, Suite 4200BERKELEY HEIGHTS, NJ, United States 07922
- Phone
- 908-517-9500
- Fax
- 302-636-5454
Executives
- Independent Chairman of the Board
- Myron Kaplan
- Chief Executive Officer, Director
- Joseph Todisco
- Chief Financial Officer, Executive Vice President
- Matthew David
- Executive Vice President, Chief Clinical Strategy and Operations Officer
- Elizabeth Massonhurlburt
- Executive Vice President, Chief Legal Officer and Corporate Secretary
- Beth Kaufman
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $604.3M |
|---|---|
Revenue (TTM) | $12.3M |
Shares Outstanding | 60.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.55 |
EPS | $-0.80 |
Book Value | $1.28 |
P/E Ratio | -12.4x |
Price/Sales (TTM) | 49.3 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -415.59% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
